BioLineRx Appoints B. J. Bormann to Board of Directors

03:13 EDT 19 Aug 2013 | PR Newswire
This article has expired, however you can still download the PDF.
JERUSALEM, Aug. 19, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today the appointment of B. J. Bormann, Ph.D., to its Board of Directors. (Logo:

Other Sources for this Article


More From BioPortfolio on "BioLineRx Appoints B. J. Bormann to Board of Directors"

Search BioPortfolio:

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...


Searches Linking to this Story